Mereo BioPharma (MREO) Depreciation and Depletion (2023 - 2025)
Mereo BioPharma (MREO) has disclosed Depreciation and Depletion for 3 consecutive years, with $36000.0 as the latest value for Q4 2025.
- Quarterly Depreciation and Depletion rose 820.0% to $36000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $274000.0 through Dec 2025, up 16.1% year-over-year, with the annual reading at $157000.0 for FY2025, 57.0% up from the prior year.
- Depreciation and Depletion for Q4 2025 was $36000.0 at Mereo BioPharma, down from $100000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $100000.0 in Q2 2023, with the low at -$5000.0 in Q4 2024.
- Average Depreciation and Depletion over 3 years is $66166.7, with a median of $71000.0 recorded in 2023.
- The sharpest move saw Depreciation and Depletion tumbled 111.9% in 2024, then skyrocketed 820.0% in 2025.
- Over 3 years, Depreciation and Depletion stood at $42000.0 in 2023, then crashed by 111.9% to -$5000.0 in 2024, then surged by 820.0% to $36000.0 in 2025.
- According to Business Quant data, Depreciation and Depletion over the past three periods came in at $36000.0, $100000.0, and $100000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.